Evaluation of cytokine production by equine alveolar macrophages exposed to lipopolysaccharide, aspergillus fumigatus, and a suspension of hat dust

American Journal of Veterinary Research

Volumn 66, Issue 9, 2005, Pages 1584-1589

  Laan, Tamarinde T J M ^a   Bull, Sarah ^a,b   Pirie, R Scott ^c   Fink Gremmels, Johanna ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; CYTOKINE; FUNGUS ANTIGEN; HOUSE DUST ALLERGEN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY OBSTRUCTION; ANIMAL CELL; ARTICLE; ASPERGILLUS FUMIGATUS; BRONCHODILATATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; DUST EXPOSURE; FEMALE; HAY; HORSE DISEASE; HOST RESISTANCE; IMMUNOMODULATION; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PATHOGENESIS; RECURRENT DISEASE; SUPERNATANT;

AIRWAY OBSTRUCTION; ANALYSIS OF VARIANCE; ANIMALS; ASPERGILLUS FUMIGATUS; CYTOKINES; DUST; HORSE DISEASES; HORSES; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; POACEAE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; ASPERGILLUS FUMIGATUS; EQUIDAE; EQUUS CABALLUS; FUNGI;

EID: 27744538894     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.1584     Document Type: Article

References (38)

1. Zhang P, Summer WR, Bagby GJ, et al. Innate immunity and pulmonary host defense. Immunol Rev 2000;173:39-51.
2. Lien E, Ingalls RR. Toll-like receptors. Crit Care Med 2002;30(suppl 1):S1-S11.
3. Strieter RM, Belperio JA, Keane MP. Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis 2003; 16:193-198.
4. Davis E, Rush BR. Equine recurrent airway obstruction: pathogenesis, diagnosis, and patient management. Vet Clin North Am Equine Pract 2002;18:453-467.
5. Lowell FC. Observations on heaves. An asthma-like syndrome in the horse. 1964. Allergy Proc 1990;11:149-150.
6. McGorum BC, Dixon PM. Evaluation of local endobronchial antigen challenges in the investigation of equine chronic obstructive pulmonary disease. Equine Vet J 1993;25:269-272.
7. Pirie RS, Collie DD, Dixon PM, et al. Inhaled endotoxin and organic dust particulates have synergistic proinflammatory effects in equine heaves (organic dust-induced asthma). Clin Exp Allergy 2003;33:676-683.
8. Lavoie JP, Maghni K, Desnoyers M, et al. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am J Respir Crit Care Med 2001;164:1410-1413.
9. Franchibi M, Gilli U, Akens MK, et al. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Vet Immunol Immunopathol 1998;66:53-65.
10. Ainsworth DM, Grunig G, Matychak MB, et al. Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells. Vet Immunol Immunopathol 2003;96:83-91.
11. Madden KS, Sanders VM, Felten DL. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 1995;35:417-448.
12. Ignatowski TA, Chou RC, Spengler RN. Changes in noradrenergic sensitivity to tumor necrosis factor-alpha in brains of rats administered clonidine. J Neuroimmunol 1996;70:55-63.
13. Farmer P, Pugin J. Beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am J Physiol Lung Cell Mol Physiol 2000; 279:L675-L682.
14. Ye RD. Beta-adrenergic agonists regulate NF-kappaB activation through multiple mechanisms. Am J Physiol Lung Cell Mol Physiol 2000;279:L615-L617.
15. McGorum BC, Ellison J, Cullen RT. Total and respirable airborne dust endotoxin concentrations in three equine management systems. Equine Vet J 1998;30:430-434.
16. Izeboud CA, Monshouwer M, Witkamp RF, et al. Suppression of the acute inflammatory response of porcine alveolar and liver macrophages. Vet Q 2000;22:26-30.
17. Northolt MD. Fungal growth on foodstuffs related to mycotoxin contamination. In: Samson RA, ed. Introduction to food borne fungi. 3rd ed. Baarn, The Netherlands: Centraal bureau voor schimmelcultures, 1998;231-238.
18. Pirie RS, Collie DD, Dixon PM, et al. Evaluation of nebulised hay dust suspensions (HDS) for the diagnosis and investigation of heaves. 2: effects of inhaled HDS on control and heaves horses. Equine Vet J 2002;34:337-342.
19. Soma LR, Uboh CE, Guan F et al. Tissue distribution of clenbuterol in the horse. J Vet Pharmacol Ther 2004;27:91-98.
20. Bertoni G, Kuhnert P, Peterhans E, et al. Improved bioassay for the detection of porcine tumor necrosis factor using a homologous cell line: PK(15). J Immunol Methods 1993;160:267-271.
21. Pauli U, Bertoni G, Duerr M, et al. A bioassay for the detection of tumor necrosis factor from eight different species: evaluation of neutralization rates of a monoclonal antibody against human TNF-alpha. J Immunol Methods 1994;171:263-265.
22. Hopkins SJ, Humphreys M. Simple, sensitive and specific bioassay of interleukin-1. J Immunol Methods 1989;120:271-276.
23. Cordeau ME, Joubert P, Dewachi O, et al. IL-4, IL-5 and IFN-gamma mRNA expression in pulmonary lymphocytes in equine heaves. Vet Immunol Immunopathol 2004;97:87-96.
24. Jackson KA, Stott JL, Horohov DW et al. IL-4 induced CD23 (Fc epsilon RII) up-regulation in equine peripheral blood mononuclear cells and pulmonary alveolar macrophages. Vet Immunol Immunopathol 2004;101:243-250.
25. Moore BD, Balasuriya UB, Watson JL, et al. Virulent and avirulent strains of equine arteritis virus induce different quantities of TNF-alpha and other proinflammatory cytokines in alveolar and blood-derived equine macrophages. Virology 2003;314:662-670.
26. Oshikawa K, Sugiyama Y. Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. Biochem Biophys Res Commun 2003;305:649-655.
27. Lin SM, Frevert CW Kajikawa O, et al. Differential regulation of membrane CD14 expression and endotoxin-tolerance in alveolar macrophages. Am J Respir Cell Mol Biol 2004;31:162-170.
28. Meier A, Kirschning Q, Nikolaus T, et al. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol 2003;5:561-570.
29. Pirie RS, Dixon PM, McGorum BC. Evaluation of nebulised hay dust suspensions (HDS) for the diagnosis and investigation of heaves. 3: effect of fractionation of HDS. Equine Vet J 2002;34:343-347.
30. Becker S, Fenton MJ, Soukup JM. Involvement of microbial components and toll-like receptors 2 and 4 in cytokine responses to air pollution particles. Am J Respir Cell Mol Biol 2002;27:611-618.
31. Takano H, Yanagisawa R, Ichinose T, et al. Diesel exhaust particles enhance lung injury related to bacterial endotoxin through expression of proinflammatory cytokines, chemokines, and intercellular adhesion molecule-1. Am J Respir Crit Care Med 2002;165:1329-1335.
32. Bernard M, Latge JP. Aspergillus fumigatus cell wall: composition and biosynthesis. Med Mycol 2001;39(suppl 1): 9-17.
33. Marr KA, Balajee SA, Hawn TR, et al. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect Immun 2003;71:5280-5286.
34. Nessa K, Palmberg L, Johard U, et al. Reaction of human alveolar macrophages to exposure to Aspergillus fumigatus and inert particles. Environ Res 1997;75:141-148.
35. Robinson NE, Derksen FJ, Olszewski MA, et al. The pathogenesis of chronic obstructive pulmonary disease of horses. Br Vet J 1996;152:283-306.
36. Izeboud CA, Mocking JA, Monshouwer M, et al. Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J Recept Signal Transduct Res 1999;19:191-202.
37. Izeboud CA, Monshouwer M, van Miert AS, et al. The beta-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivo. Inflamm Res 1999;48:497-502.
38. Izeboud CA, Vermeulen RM, Zwart A, et al. Stereoselectivity at the beta2-adrenoceptor on macrophages is a major determinant of the anti-inflammatory effects of beta2-agonists. Naunyn Schmiedebergs Arch Pharmacol 2000;362:184-189.